Skip to main content

Peer Review reports

From: Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine

Original Submission
11 Jun 2020 Submitted Original manuscript
15 Jul 2020 Author responded Author comments - Rie Nishi
Resubmission - Version 2
15 Jul 2020 Submitted Manuscript version 2
23 Jul 2020 Reviewed Reviewer Report
6 Aug 2020 Reviewed Reviewer Report - Jalaj Gupta
2 Sep 2020 Author responded Author comments - Rie Nishi
Resubmission - Version 3
2 Sep 2020 Submitted Manuscript version 3
3 Sep 2020 Reviewed Reviewer Report
19 Sep 2020 Reviewed Reviewer Report - Jalaj Gupta
25 Sep 2020 Author responded Author comments - Rie Nishi
Resubmission - Version 4
25 Sep 2020 Submitted Manuscript version 4
Publishing
29 Sep 2020 Editorially accepted
12 Oct 2020 Article published 10.1186/s12885-020-07469-x

You can find further information about peer review here.

Back to article page